Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy — Min Wu (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy
Shared by
Paul Kim Ho Chu
Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy
Article
2017
en
Authors
+6 more
MW
Min Wu
XL
Xingang Liu
WJ
Weihong Jin
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2017
Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy
Weihong Jin
,
Qiwen Wang
,
Min Wu
,
Yang Li
,
Guping Tang
,
Ping Yuan
,
Paul Kim Ho Chu
Article
2021
Targeting Multidrug‐Resistant Bacteria: Efficient Killing of Multidrug‐Resistant Internalized Bacteria by AIEgens In Vivo (Adv. Sci. 9/2021)
Ying Li
,
Fei Liu
,
Jiangjiang Zhang
,
Xiaoye Liu
,
Peihong Xiao
,
Haotian Bai
,
Shang Chen
,
Dong Wang
,
Simon H. P. Sung
,
Ryan T. K. Kwok
,
Jianzhong Shen
,
Kui Zhu
,
Ben Zhong Tang
Article
2010
Targeting mitochondria for cancer therapy
Simone Fulda
,
Lorenzo Galluzzi
,
Guido Guido Kroemer
Article
2025
Targeting macropinocytosis for cancer therapy
Daolin Tang
,
Jiayi Wang
,
Guido Guido Kroemer
,
Rui Kang
Article
2009
Targeting HSP70 for Cancer Therapy
Guido Guido Kroemer
,
Lorenzo Galluzzi
,
Fabrizio Giordanetto
Discussion(0)
No comments yet. Be the first to comment.